Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Receivables - Other (2018 - 2025)

Historic Receivables - Other for Biomerica (BMRA) over the last 8 years, with Q4 2025 value amounting to $1.0 million.

  • Biomerica's Receivables - Other fell 2291.2% to $1.0 million in Q4 2025 from the same period last year, while for Nov 2025 it was $1.0 million, marking a year-over-year decrease of 2291.2%. This contributed to the annual value of $757000.0 for FY2025, which is 2163.56% down from last year.
  • Latest data reveals that Biomerica reported Receivables - Other of $1.0 million as of Q4 2025, which was down 2291.2% from $1.3 million recorded in Q3 2025.
  • Biomerica's 5-year Receivables - Other high stood at $2.3 million for Q2 2021, and its period low was $751000.0 during Q2 2023.
  • Its 5-year average for Receivables - Other is $1.2 million, with a median of $1.2 million in 2024.
  • In the last 5 years, Biomerica's Receivables - Other tumbled by 5955.5% in 2022 and then skyrocketed by 2862.85% in 2024.
  • Biomerica's Receivables - Other (Quarter) stood at $2.3 million in 2021, then tumbled by 59.55% to $927000.0 in 2022, then rose by 17.48% to $1.1 million in 2023, then increased by 24.24% to $1.4 million in 2024, then dropped by 22.91% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q4 2025, $1.3 million for Q3 2025, and $757000.0 during Q2 2025.